Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06508255

Time-restricted Eating and Cognition

Time-restricted Eating and Cognition (ChronoBEAT)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
German Institute of Human Nutrition · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate how time-restricted eating (TRE), more specifically TRE at different times (early vs late in the day), influences brain activity, behavior, decision-making, food intake, physical activity, the gut microbiome and metabolic processes. The study intervention procedure is a replication of that described in Peters et al. (2021).

Detailed description

This study aims to investigate the effects of different time-restricted eating (TRE) interventions on decision-making, brain activity and related processes in an all female cohort over 8 weeks. The study will have a within-subjects, randomised, crossover design, involving two TRE interventions with a comparable feeding and fasting window of 8:16h respectively- early TRE (eating window: 08:00-16:00) and late TRE (eating window: 13:00-21:00). After completing a screening visit, participants will complete a two-week observational phase in which they record their habitual food intake, as well as sleep and physical activity assessment. After this observational phase, participants will be randomly assigned to one of two study arms (early TRE/late TRE or late TRE/early TRE). Here they will complete both TRE interventions for two weeks each, separated by a washout phase of two weeks. During these phases they will record their food intake and physical activity and sleep will be assessed. The participants will be invited for 4 laboratory study visits during this time, at the beginning and end of each TRE intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEarly Time-Restricted EatingEat between 8:00 and 16:00 for 2 weeks
BEHAVIORALLate Time-Restricted EatingEat between 13:00 and 21:00 for 2 weeks

Timeline

Start date
2024-05-17
Primary completion
2025-03-01
Completion
2025-03-01
First posted
2024-07-18
Last updated
2024-07-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06508255. Inclusion in this directory is not an endorsement.